Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Terranova’s Stephen Bittel Donates $450,000 to Parkinson’s Foundation to Support Expansion of Centers of Excellence Network

MIAMI – February 1, 2018 – The Parkinson’s Foundation today announced that Stephen Bittel, chairman and founder of Terranova, has made a $450,000 donation to support the expansion of the foundation’s Centers of Excellence network. Additionally, Bittel, who manages Terranova’s commercial real estate portfolio valued over $1 billion, pledged to raise an additional $1 million to fund ongoing fellowship grants.

Parkinson’s, which currently affects an estimated one million Americans and 10 million people worldwide, is the second-most common neurodegenerative disease after Alzheimer’s and the 14th-leading cause of death in the United States.

“We are extremely grateful for Stephen’s generous donation and his ongoing support of our mission,” said John L. Lehr, CEO of the Parkinson’s Foundation. “His contributions will have a significant impact on our community, as we continue to lead the charge in making life better for people with Parkinson’s and working toward a cure.”

Bittel’s donation will support the Parkinson’s Foundation’s Centers of Excellence network, which is comprised of 42 medical centers in the U.S. and worldwide and allows the foundation to set the standard of care for Parkinson’s and lead the development of new treatments and care models. Led by renowned clinicians in Parkinson’s care, the centers deliver care to more than 100,000 individuals with Parkinson’s every year. Parkinson’s Foundation Center of Excellence status is the most respected and sought-after designation in the field of Movement Disorders, with each center required to meet rigorous clinical, research, professional education, and patient service criteria.

Bittel also pledged to leverage his personal and professional networks to raise $1 million to support the Parkinson’s Foundation’s fellowship grants. The grants are awarded annually to encourage young scientists, clinicians and students to devote their talents to the study of Parkinson's disease.

Said Bittel: “As part of my ongoing commitment to giving back and supporting our community, I am grateful for the opportunity to support the Parkinson’s Foundation, an organization that is truly making an impact and working hard to advance a greater good.”   

Bittel first became involved with the organization after seeing the impact of the disease on his Executive Vice President Mindy McIlroy, who was diagnosed with Parkinson’s in 2014. The news made her determined to tackle her Parkinson's condition head-on and summon all her resources at a personal and community level to pursue a cure. While continuing her responsibilities at Terranova, Mindy joined the Board of Directors of the Parkinson’s Foundation and became chair of Moving Day Miami, a walk for Parkinson’s, in 2014 and remained a co-chair in 2015. This year, Mindy also became co-chair of the Parkinson’s Foundation’s Development Committee. In 2014, Team Terranova at Moving Day Miami was the first in the organization’s history to raise more than $100,000, thanks to Bittel’s offer to personally match every dollar raised.

Over the years, Terranova’s involvement with the foundation has included serving as presenting sponsor of Moving Day Miami (2014 – 2016) and earning the distinction of Moving Day Miami’s Top Corporate Team (2014 – 2017).

###

About the Parkinson’s Foundation
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. For more information, visit www.parkinson.org or call (800) 4PD-INFO (473-4636).

About Parkinson’s Disease
Affecting an estimated one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety A feeling of nervousness, worried thoughts and physical distress.). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the United States alone.

Thursday, February 1, 2018
Parkinson’s Foundation Welcomes Paul H. Nathan to Board of Directors
Wednesday, May 3, 2017

New York, NY and Miami, FL — The Parkinson’s Foundation is pleased to announce the election of financial services executive Paul H. Nathan of San Francisco, CA, to its Board of Directors. The appointment was announced following a meeting of the board on April 27.

Parkinson’s Foundation to Host “World Without Parkinson’s” Scientific Symposium on June 1 in NYC
Friday, April 21, 2017

The Parkinson’s Foundation invites health innovators to join World Without Parkinson’s on Thursday, June 1 in New York, NY. The cutting-edge scientific event marks the 200th anniversary of James Parkinson’s, “An Essay on the Shaking Palsy.”

FDA Allows Marketing of a Genetic Test for Medical Conditions Including Parkinson’s
Thursday, April 6, 2017

Earlier today, the US Food and Drug Administration (FDA) announced that it will allow direct marketing to consumers of a genetic test that identifies predispositions for 10 medical conditions, including Parkinson’s. Such tests are referred to as direct-to-consumer or DTC.

Parkinson’s Foundation to Host 60th Anniversary Gala on Wednesday, May 31
Monday, March 20, 2017

The 60th Anniversary Gala to benefit Parkinson’s Foundation will take place Wednesday, May 31, 2017 in the Garden Terrace Room at the New York Botanical Garden in the Bronx, NY.  The Gala marks the 60th Anniversary of both the Parkinson ’s Disease Foundation (PDF) and the National Parkinson Foundation (NPF), the legacy organizations of the Parkinson’s Foundation and recognizes their

Parkinson’s Foundation Mourns the Passing of Lewis P. Rowland, M.D.
Friday, March 17, 2017

The Parkinson’s Foundation mourns the loss of Lewis P. “Bud” Rowland, M.D., Emeritus member of its Board of Directors and longtime champion of its work to end Parkinson’s. Dr. Rowland, who also served as President of the Parkinson’s Disease Foundation (PDF) division of the Parkinson’s Foundation for many years, passed away on March 16.

Local Residents Raise Nearly $40,000 for Parkinson’s Research at Scotch & Sangria Event in Closter, NJ
Thursday, March 9, 2017

Proceeds From Fourth Annual Helping Hours Event Benefit Parkinson’s Foundation

Advocates Guide $16 Million in US Department of Defense Parkinson’s Research Funding for Second Straight Year
Tuesday, March 7, 2017

Recently, four Parkinson’s Foundation Research Advocates helped guide $16 million in government funding for Parkinson’s disease (PD) research. This is the second straight year in which our Research Advocates have served as consumer reviewers for research funded by the US Department of Defense (DoD). The group included:

Parkinson’s Foundation Receives Award to Develop National Recommendations to Improve Care for Women with Parkinson’s
Tuesday, February 28, 2017

NEW YORK CITY & MIAMI — The Parkinson's Foundationhas received a $250,000 award to develop new patient-centered recommendations to improve the health of women living with Parkinson’s disease.

Parkinson’s Foundation Invests $500,000 in Community-Driven Clinical Research To Ease Cognition, Sleep and Fatigue in Parkinson’s
Monday, February 27, 2017

Five New Awards Address Unmet Needs

New York, NY and Miami, FL — The Parkinson’s Foundation has awarded $500,000 for translational research grants to address critical unmet needs in Parkinson’s disease.  The investments jumpstart practical solutions to ease difficulties related to cognition, fatigue and sleep, all of which are debilitating yet under-recognized symptoms in Parkinson’s.

The Parkinson's Foundation’s Moving Day® Walks Fund Local Parkinson’s Programs in 2017
Monday, February 13, 2017

$13.7 million dollars raised over five years
 

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.